Cargando…

The use of assisted reproductive technology before male factor infertility evaluation

BACKGROUND: Some centers offer assisted reproductive technologies (ARTs) [intra-uterine insemination (IUI) and in-vitro fertilization (IVF)], to treat certain couples with male factor infertility without having the men assessed by male infertility specialists. We sought to compare characteristics of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nayan, Madhur, Punjani, Nahid, Grober, Ethan, Lo, Kirk, Jarvi, Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127534/
https://www.ncbi.nlm.nih.gov/pubmed/30211059
http://dx.doi.org/10.21037/tau.2018.06.08
_version_ 1783353492502478848
author Nayan, Madhur
Punjani, Nahid
Grober, Ethan
Lo, Kirk
Jarvi, Keith
author_facet Nayan, Madhur
Punjani, Nahid
Grober, Ethan
Lo, Kirk
Jarvi, Keith
author_sort Nayan, Madhur
collection PubMed
description BACKGROUND: Some centers offer assisted reproductive technologies (ARTs) [intra-uterine insemination (IUI) and in-vitro fertilization (IVF)], to treat certain couples with male factor infertility without having the men assessed by male infertility specialists. We sought to compare characteristics of couples having or not having prior ART use. METHODS: We used our prospectively collected database to identify men undergoing an initial evaluation for male infertility between 1995–2017. We obtained data on patient demographics, use of IUI and IVF, and semen analysis parameters. We used multivariable logistic regression to identify characteristics associated with prior use of ART. RESULTS: One thousand and five hundred forty-five out of 8,962 (17.2%) men reported use of ARTs prior to evaluation. Of these, 258 tried both IUI and IVF. More than one attempt was reported in 470 (37.2%) and 154 (28.2%) of men with prior IUI and IVF, respectively. Younger male age [adjusted odds ratio (aOR) 0.97/year; 95% confidence interval (CI), 0.95 to 0.99], older female partner age (aOR 1.07/year; 95% CI, 1.04 to 1.10), and year of visit (aOR 1.05/year; 95% CI, 1.01 to 1.09) were significantly associated with prior IUI. Older female partner age (aOR 1.07/year; 95% CI, 1.02 to 1.12) was significantly associated with prior IVF, but not male age or year of visit. Semen analysis parameters were not associated with prior ART. CONCLUSIONS: The prior use of ART is common among men presenting for an initial evaluation at a male infertility specialty clinic. Older female partner age was associated with use of reproductive technologies prior to evaluation, however, semen analysis parameters were not.
format Online
Article
Text
id pubmed-6127534
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-61275342018-09-12 The use of assisted reproductive technology before male factor infertility evaluation Nayan, Madhur Punjani, Nahid Grober, Ethan Lo, Kirk Jarvi, Keith Transl Androl Urol Original Article BACKGROUND: Some centers offer assisted reproductive technologies (ARTs) [intra-uterine insemination (IUI) and in-vitro fertilization (IVF)], to treat certain couples with male factor infertility without having the men assessed by male infertility specialists. We sought to compare characteristics of couples having or not having prior ART use. METHODS: We used our prospectively collected database to identify men undergoing an initial evaluation for male infertility between 1995–2017. We obtained data on patient demographics, use of IUI and IVF, and semen analysis parameters. We used multivariable logistic regression to identify characteristics associated with prior use of ART. RESULTS: One thousand and five hundred forty-five out of 8,962 (17.2%) men reported use of ARTs prior to evaluation. Of these, 258 tried both IUI and IVF. More than one attempt was reported in 470 (37.2%) and 154 (28.2%) of men with prior IUI and IVF, respectively. Younger male age [adjusted odds ratio (aOR) 0.97/year; 95% confidence interval (CI), 0.95 to 0.99], older female partner age (aOR 1.07/year; 95% CI, 1.04 to 1.10), and year of visit (aOR 1.05/year; 95% CI, 1.01 to 1.09) were significantly associated with prior IUI. Older female partner age (aOR 1.07/year; 95% CI, 1.02 to 1.12) was significantly associated with prior IVF, but not male age or year of visit. Semen analysis parameters were not associated with prior ART. CONCLUSIONS: The prior use of ART is common among men presenting for an initial evaluation at a male infertility specialty clinic. Older female partner age was associated with use of reproductive technologies prior to evaluation, however, semen analysis parameters were not. AME Publishing Company 2018-08 /pmc/articles/PMC6127534/ /pubmed/30211059 http://dx.doi.org/10.21037/tau.2018.06.08 Text en 2018 Translational Andrology and Urology. All rights reserved.
spellingShingle Original Article
Nayan, Madhur
Punjani, Nahid
Grober, Ethan
Lo, Kirk
Jarvi, Keith
The use of assisted reproductive technology before male factor infertility evaluation
title The use of assisted reproductive technology before male factor infertility evaluation
title_full The use of assisted reproductive technology before male factor infertility evaluation
title_fullStr The use of assisted reproductive technology before male factor infertility evaluation
title_full_unstemmed The use of assisted reproductive technology before male factor infertility evaluation
title_short The use of assisted reproductive technology before male factor infertility evaluation
title_sort use of assisted reproductive technology before male factor infertility evaluation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127534/
https://www.ncbi.nlm.nih.gov/pubmed/30211059
http://dx.doi.org/10.21037/tau.2018.06.08
work_keys_str_mv AT nayanmadhur theuseofassistedreproductivetechnologybeforemalefactorinfertilityevaluation
AT punjaninahid theuseofassistedreproductivetechnologybeforemalefactorinfertilityevaluation
AT groberethan theuseofassistedreproductivetechnologybeforemalefactorinfertilityevaluation
AT lokirk theuseofassistedreproductivetechnologybeforemalefactorinfertilityevaluation
AT jarvikeith theuseofassistedreproductivetechnologybeforemalefactorinfertilityevaluation
AT nayanmadhur useofassistedreproductivetechnologybeforemalefactorinfertilityevaluation
AT punjaninahid useofassistedreproductivetechnologybeforemalefactorinfertilityevaluation
AT groberethan useofassistedreproductivetechnologybeforemalefactorinfertilityevaluation
AT lokirk useofassistedreproductivetechnologybeforemalefactorinfertilityevaluation
AT jarvikeith useofassistedreproductivetechnologybeforemalefactorinfertilityevaluation